Olivier Peyrony

Dr. Olivier Peyrony

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in Annals of Internal Medicine
Verified
Journal Article
Open access
DBDonia Bouzid
Donia Bouzid
BVBenoit Visseaux
Benoit Visseaux
CKChristian Kassasseya
Christian Kassasseya
ADAsma Daoud
Asma Daoud
FFFlorent Fémy
Florent Fémy
IGIMProving Emergency Care (IMPEC) FHU Collaborators Group*
IMProving Emergency Care (IMPEC) FHU Collaborators Group*
At the end of 2021, infections with the B.1.1.529 SARS-CoV-2 variant (Omicron) superseded those with the B.1.617.2 variant (Delta). This study compares baseline characteristics and in-hospital outc... Visual Patients With Delta Versus Omicron Variants in the Emergency Department. At the end of 2021, infections with the B.1.1.529 SARS-CoV-2 variant (Omicron) superseded those with the B.1... Background: At the end of 2021, the B.1.1.529 SARS-CoV-2 variant (Omicron) wave superseded the B.1.617.2 variant (Delta) wave. Objective: To compare baseline characteristics and in-hospital outcome...

1 October 2020 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
OPOlivier Peyrony
Olivier Peyrony
CMCarole Marbeuf-Gueye
Carole Marbeuf-Gueye
VTVy Truong
Vy Truong
MGMarion Giroud
Marion Giroud
CRClémentine Rivière
Clémentine Rivière
JFJean-Paul Fontaine
Jean-Paul Fontaine

20 August 2021 in Science Advances
Verified
Journal Article
Open access
NYNader Yatim
Nader Yatim
JBJeremy Boussier
Jeremy Boussier
PTPauline Tetu
Pauline Tetu
NSNikaïa Smith
Nikaïa Smith
TBTimothée Bruel
Timothée Bruel
Céleste LebbéCéleste Lebbé
Céleste Lebbé
Immune checkpoint inhibitors for melanoma improve adaptive T cell immunity during COVID-19 without exacerbating inflammation.

1 June 2023 in Annals of Internal Medicine
Verified
Journal Article
Closed access
MRMelanie Roussel
Melanie Roussel
BBBen Bloom
Ben Bloom
MTMehdi Taalba
Mehdi Taalba
CCChristophe Choquet
Christophe Choquet
DDDelphine Douillet
Delphine Douillet
YYYouri Yordanov
Youri Yordanov
Recently, validated clinical decision rules have been developed that avoid unnecessary use of computed tomographic pulmonary angiography (CTPA) in patients with suspected pulmonary embolism (PE) in the emergency department (ED). To measure any resulting change in CTPA use for suspected PE. Retrospective analysis. 26 European EDs in 6 countries. Patients with CTPA performed for suspected PE in the ED during the first 7 days of each odd month between January 2015 and December 2019. The primary end points were the CTPAs done for suspected PE in the ED and the number of PEs diagnosed in the ED each year adjusted to an annual census of 100 000 ED visits. Temporal trends were estimated using generalized linear mixed regression models. 8970 CTPAs were included (median age, 63 years; 56% female). Statistically significant temporal trends for more frequent use of CTPA (836 per 100 000 ED visits in 2015 vs. 1112 in 2019; P < 0.001), more diagnosed PEs (138 per 100 000 in 2015 vs. 164 in 2019; P = 0.028), a higher proportion of low-risk PEs (annual percent change [APC], 13.8% [95% CI, 2.6% to 30.1%]) with more ambulatory management (APC, 19.3% [CI, 4.1% to 45.1%]), and a lower proportion of intensive care unit admissions (APC, -8.9% [CI, -17.1% to -0.3%]) were observed. Data were limited to 7 days every 2 months. Despite the recent validation of clinical decision rules to limit the use of CTPA, an increase in the CTPA rate along with more diagnosed PEs and especially low-risk PEs were instead observed. None specific for this study.

1 September 2020 in International Journal of Hygiene and Environmental Health
Verified
Journal Article
Closed access
OPOlivier Peyrony
Olivier Peyrony
SESami Ellouze
Sami Ellouze
JFJean-Paul Fontaine
Jean-Paul Fontaine
MCMicheline Thegat-Le Cam
Micheline Thegat-Le Cam
MSMaud Salmona
Maud Salmona
MTM.T. Tremorin
M.T. Tremorin

Enrique CasalinoEnrique Casalino
Enrique Casalino
CCChristophe Choquet
Christophe Choquet
DBDonia Bouzid
Donia Bouzid
OPOlivier Peyrony
Olivier Peyrony
SCSonja Curac
Sonja Curac
DGDaniel Aiham GHAZALI
Daniel Aiham GHAZALI
ED-visits and through-ED admissions to medical/surgical wards (MSW) and intensive care unit (ICU) during influenza, COVID-19 and lockdown periods were evaluated in a four-hospital prospective observational study from November 2018 to March 2020. ED visit characteristics and main diagnostic categories were assessed. Analysis of 368,262 ED-visits highlighted a significantly increasing trend in ED-visits during influenza followed by a significantly decreasing trend after lockdown. For MSW-admissions, a pattern of growth during influenza was followed by a fall that began during COVID-19 pandemic and intensified during the lockdown. For ICU-admissions, a significant rise during the COVID-19 pandemic was followed by diminution during the lockdown period. During lockdown, significantly diminishing trends were shown for all diagnostic categories (between −40.8% and −73.6%), except influenza-like illness/COVID cases (+31.6%), Pulmonary embolism/deep vein thrombosis (+33.5%) and frequent users (+188.0%). The present study confirms an increase in demand during the influenza epidemic and during the initial phase of the COVID-19 epidemic, but a drop in activity during the lockdown, mainly related to non-COVID conditions. Syndromic surveillance of ILI cases in ED is a tool for monitoring influenza and COVID-19, and it can predict ED activity and the need for MSW and ICU beds.